Human telomerase reverse transcriptase
CA 2267664 C · Owner: Morin, Gregg B. · Inventors: Lingner, Joachim; Cech, Thomas R.; Chapman, Karen B.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention provides compositions and methods related to human telomerase reverse transcriptase (hTRT), the catalytic protein subunit of human telomerase. The , polynucleotides and polypeptides of the invention are useful for diagnosis prognosis and , treatment of human diseases for changing the proliferative capacity of cells and , organisms, and for identification and screening of compounds and treatments useful for , treatment of diseases such as cancers.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 1, 1997 and granted June 11, 2013. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended October 1, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 1, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.